Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-101226
Filing Date
2024-08-28
Accepted
2024-08-28 07:00:19
Documents
52
Period of Report
2024-08-28

Document Format Files

Seq Description Document Type Size
1 6-K i_-_mab_6k_mid_year_2024.htm 6-K 26324
2 EX-99.1 imab-ex99_1.htm EX-99.1 410153
3 EX-99.2 imab-ex99_2.htm EX-99.2 34092
4 EX-99.3 imab-ex99_3.htm EX-99.3 35896
5 GRAPHIC imab-ex99_2s1.jpg GRAPHIC 227527
6 GRAPHIC imab-ex99_2s2.jpg GRAPHIC 972749
7 GRAPHIC imab-ex99_2s3.jpg GRAPHIC 224995
8 GRAPHIC imab-ex99_2s4.jpg GRAPHIC 503596
9 GRAPHIC imab-ex99_2s5.jpg GRAPHIC 361220
10 GRAPHIC imab-ex99_2s6.jpg GRAPHIC 420029
11 GRAPHIC imab-ex99_2s7.jpg GRAPHIC 297406
12 GRAPHIC imab-ex99_2s8.jpg GRAPHIC 466531
13 GRAPHIC imab-ex99_2s9.jpg GRAPHIC 421053
14 GRAPHIC imab-ex99_2s10.jpg GRAPHIC 405039
15 GRAPHIC imab-ex99_2s11.jpg GRAPHIC 362165
16 GRAPHIC imab-ex99_2s12.jpg GRAPHIC 319594
17 GRAPHIC imab-ex99_2s13.jpg GRAPHIC 343983
18 GRAPHIC imab-ex99_2s14.jpg GRAPHIC 528091
19 GRAPHIC imab-ex99_2s15.jpg GRAPHIC 432125
20 GRAPHIC imab-ex99_2s16.jpg GRAPHIC 364681
21 GRAPHIC imab-ex99_2s17.jpg GRAPHIC 454910
22 GRAPHIC imab-ex99_2s18.jpg GRAPHIC 415407
23 GRAPHIC imab-ex99_2s19.jpg GRAPHIC 420192
24 GRAPHIC imab-ex99_2s20.jpg GRAPHIC 468667
25 GRAPHIC imab-ex99_2s21.jpg GRAPHIC 422607
26 GRAPHIC imab-ex99_2s22.jpg GRAPHIC 416441
27 GRAPHIC imab-ex99_2s23.jpg GRAPHIC 218424
28 GRAPHIC imab-ex99_3s1.jpg GRAPHIC 212051
29 GRAPHIC imab-ex99_3s2.jpg GRAPHIC 975977
30 GRAPHIC imab-ex99_3s3.jpg GRAPHIC 419991
31 GRAPHIC imab-ex99_3s4.jpg GRAPHIC 297440
32 GRAPHIC imab-ex99_3s5.jpg GRAPHIC 379899
33 GRAPHIC imab-ex99_3s6.jpg GRAPHIC 466492
34 GRAPHIC imab-ex99_3s7.jpg GRAPHIC 353963
35 GRAPHIC imab-ex99_3s8.jpg GRAPHIC 359533
36 GRAPHIC imab-ex99_3s9.jpg GRAPHIC 422077
37 GRAPHIC imab-ex99_3s10.jpg GRAPHIC 270100
38 GRAPHIC imab-ex99_3s11.jpg GRAPHIC 365951
39 GRAPHIC imab-ex99_3s12.jpg GRAPHIC 405042
40 GRAPHIC imab-ex99_3s13.jpg GRAPHIC 362222
41 GRAPHIC imab-ex99_3s14.jpg GRAPHIC 345727
42 GRAPHIC imab-ex99_3s15.jpg GRAPHIC 479247
43 GRAPHIC imab-ex99_3s16.jpg GRAPHIC 405840
44 GRAPHIC imab-ex99_3s17.jpg GRAPHIC 432058
45 GRAPHIC imab-ex99_3s18.jpg GRAPHIC 475038
46 GRAPHIC imab-ex99_3s19.jpg GRAPHIC 528115
47 GRAPHIC imab-ex99_3s20.jpg GRAPHIC 364651
48 GRAPHIC imab-ex99_3s21.jpg GRAPHIC 454888
49 GRAPHIC imab-ex99_3s22.jpg GRAPHIC 415898
50 GRAPHIC imab-ex99_3s23.jpg GRAPHIC 392460
51 GRAPHIC imab-ex99_3s24.jpg GRAPHIC 412475
52 GRAPHIC imab-ex99_3s25.jpg GRAPHIC 235505
  Complete submission text file 0000950170-24-101226.txt   27634192
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 241251021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)